Malin Corporation | MLC - Debt


Malin Corporation reported EUR100K in Debt for its fiscal semester ending in December of 2023.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
ALKERMES USD 1.58B 1.51B Mar/2026
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Eurofins Scientific SE EUR 4.43B 318.3M Dec/2025
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
Lonza CHF 4.71B 915M Dec/2024
Malin Corporation EUR 100K 0 Dec/2023
Moderna USD 1.3B 7M Mar/2026
Organon & Co USD 8.57B 75M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 3.35B 48.03M Mar/2026
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 13.35B 993.3M Jun/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026